+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 485800-26-8
485800-26-8,MFCD00274335
Catalog No.:AA00I8PR

485800-26-8 | T-Boc-cystamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$120.00   $84.00
- +
1g
95%
in stock  
$203.00   $142.00
- +
5g
95%
in stock  
$390.00   $273.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00I8PR
Chemical Name:
T-Boc-cystamine
CAS Number:
485800-26-8
Molecular Formula:
C9H20N2O2S2
Molecular Weight:
252.3973
MDL Number:
MFCD00274335
SMILES:
NCCSSCCNC(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
183  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
8  
XLogP3:
0.7  

Downstream Synthesis Route

[1]Erlanson,DanielA.;McDowell,RobertS.;He,MollyM.;Randal,Mike;Simmons,RobertL.;Kung,Jenny;Waight,Andrew;Hansen,StigK.[JournaloftheAmericanChemicalSociety,2003,vol.125,#19,p.5602-5603]

[2]CurrentPatentAssignee:SUNESISPHARMACEUTICALSINC-EP2257637,2015,B1Locationinpatent:Paragraph0157

147900-45-6    485800-26-8   
{4-2-(2-tert-butoxycarbonylamino-ethyldisulfanyl)-ethylcarbamoyl-cyclohexyl}-carbamicacid9H-fluoren-9-ylmethylester 

[1]Erlanson,DanielA.;McDowell,RobertS.;He,MollyM.;Randal,Mike;Simmons,RobertL.;Kung,Jenny;Waight,Andrew;Hansen,StigK.[JournaloftheAmericanChemicalSociety,2003,vol.125,#19,p.5602-5603]

485800-26-8    614760-53-1   
<i>N</i>-{4-2-(2-<i>tert</i>-butoxycarbonylamino-ethyldisulfanyl)-ethylcarbamoyl-phenyl}-oxalamicacid<i>tert</i>-butylester 

[1]Erlanson,DanielA.;McDowell,RobertS.;He,MollyM.;Randal,Mike;Simmons,RobertL.;Kung,Jenny;Waight,Andrew;Hansen,StigK.[JournaloftheAmericanChemicalSociety,2003,vol.125,#19,p.5602-5603]

485800-26-8    676371-81-6   
(2-{2-3-bromomethyl-5-(3-trifluoromethyl-3<i>H</i>-diazirin-3-yl)-benzylamino-ethyldisulfanyl}-ethyl)-carbamicacid<i>tert</i>-butylester 

[1]Halbfinger,Efrat;Gorochesky,Karine;Levesque,SebastienA.;Beaudoin,AdrienR.;Sheihet,Larisa;Margel,Shlomo;Fischer,Bilha[OrganicandBiomolecularChemistry,2003,vol.1,#16,p.2821-2832]

[1]Halbfinger,Efrat;Gorochesky,Karine;Levesque,SebastienA.;Beaudoin,AdrienR.;Sheihet,Larisa;Margel,Shlomo;Fischer,Bilha[OrganicandBiomolecularChemistry,2003,vol.1,#16,p.2821-2832]

Literature

Title: RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping.

Journal: International journal of nanomedicine 20070601

Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 485800-26-8
93790-49-9

93790-49-9

 93790-49-9

93790-49-9

 1053178-96-3

1053178-96-3

 877864-07-8

877864-07-8

 144700-78-7

144700-78-7

 1864115-32-1

1864115-32-1
Building Blocks
More >
Tags:485800-26-8 Molecular Formula|485800-26-8 MDL|485800-26-8 SMILES|485800-26-8 T-Boc-cystamine